Form 4: Cyanotech Corp: Chief Scientific Officer Reports Stock Transactions

Gerald R. Cysewski, Chief Scientific Officer of Cyanotech Corp, reports the vesting of restricted stock units and withholding of shares for tax obligations.

Summary

• On July 29, 2024, Gerald R. Cysewski, the Chief Scientific Officer of Cyanotech Corp, reported transactions involving the company's common stock.
• 1,576 restricted stock units vested and were converted into common stock.
• The company withheld 592 shares to cover payroll tax liabilities associated with the vesting.
• Following these transactions, Cysewski directly owns 143,256 shares of common stock and indirectly owns 250 shares held by his spouse.
• He also holds 5,544 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects standard insider transactions related to compensation. There are no explicit positive or negative implications for the company's performance.

Positives

• The vesting of restricted stock units indicates a form of compensation and alignment of the officer's interests with the company's performance.

Future Outlook

The reporting person has remaining restricted stock units that will vest in the future, subject to continued service with the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for investor confidence and regulatory compliance.

Comparison to Industry Standards

• Insider transactions are common across publicly traded companies and are regulated by the SEC.
• The vesting of restricted stock units is a typical form of executive compensation, aligning management's interests with shareholders.
• Companies like Nutanix and Tesla also use stock-based compensation for their executives.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding insider activity.
• The vesting of stock units incentivizes the Chief Scientific Officer to contribute to the company's success.

Key Dates

Keywords

Form 4, Beneficial Ownership, Restricted Stock Units, Vesting, Cyanotech, CYAN, Cysewski, Insider Trading